Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 28.11% Profit Margin

May 03, 2023
QuantWave, a leading automated forecasting platform, successfully predicted a long trading opportunity for ELI LILLY AND COMPANY stock on February 6th, with a price target of $423.98. The forecast signal date indicated a price of $330.94, and on May 3rd, the stock reached the predicted target, resulting in a 28.11% profit margin for investors.

The achievement of this price target forecast showcases the accuracy and effectiveness of QuantWave's analytics in guiding investors towards profitable trading decisions. With detailed market analysis and precise predictions, QuantWave offers users the opportunity to capitalize on market movements and generate significant returns on investment.

ELI LILLY AND COMPANY's stock movement may have been influenced by various factors, including positive developments in the pharmaceutical industry, company-specific news, and overall market trends. QuantWave's advanced algorithms and forecasting models analyze these factors to provide actionable insights and profitable trading opportunities.

QuantWave's success in forecasting ELI LILLY AND COMPANY's stock price movement highlights the platform's capability to deliver valuable predictions for a wide range of stocks. Investors can leverage QuantWave's automated forecasting system to make informed trading decisions and maximize their investment returns.

For investors looking to enhance their trading strategies and delve deeper into QuantWave's forecasting system, QuantSchool offers comprehensive educational resources. QuantSchool equips users with the key principles and professional investment frameworks necessary to leverage the QuantWave platform effectively and generate consistent income from their investments.

Find out how the ELI LILLY AND COMPANY rate is expected to change

Get Forecast for LLY
There are no comments yet. Be the first to leave a comment
If you want to leave a comment, then you need Login or Register





Other news for LLY

LLYMarch 22, 2025Eli Lilly and Company LLY: Leading the Way in Pharmaceutical Innovation  ~2 min.

Eli Lilly and Company (LLY) continues to make waves in the pharmaceutical industry with its innovative and groundbreaking therapies....

LLYMarch 19, 2025Eli Lilly and Company LLY Surges After Breakthrough BRAVE-AA-PEDS Study Results  ~2 min.

Eli Lilly and Company (LLY) has recently made a significant breakthrough in its BRAVE-AA-PEDS study, resulting in a surge of investor attention and market gains....

LLYMarch 18, 2025Eli Lilly and Company: A Promising Investment in the Pharma Industry  ~1 min.

Eli Lilly and Company (LLY) has been making waves in the pharmaceutical industry with its innovative products and strong performance....

LLYMarch 17, 2025Eli Lilly and Company's Groundbreaking Discovery Revolutionizes Pharma Industry  ~2 min.

Eli Lilly and Company, a renowned pharmaceutical giant, has recently made a groundbreaking discovery that is set to revolutionize the entire industry....

LLYMarch 16, 2025Is Eli Lilly and Company LLY Set to Revolutionize the Pharma Industry?  ~2 min.

Eli Lilly and Company (LLY) has been making headlines recently with its groundbreaking research and innovative products....



Related news

REGNApril 4, 2025REGENERON PHARMACEUTICALS, INC. Hits QuantWave Forecast Target with Profit of 15.56%  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave on April 4, 2025....

VRTXMarch 17, 2025VERTEX PHARMACEUTICALS INCORPORATED Hits Forecast Price Target with a Profit of 9.49%  ~1 min.

VERTEX PHARMACEUTICALS INCORPORATED has successfully reached the forecast price target set by QuantWave on December 17, 2024. The forecast signal indicated a "long" direction with a price of $469....

REGNApril 10, 2025REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 17.79% Profit: QuantWave's Success  ~1 min.

REGENERON PHARMACEUTICALS, INC. has successfully reached the price target forecast set by QuantWave, resulting in a profit of 17.79%....

VJune 30, 2023QuantWave Hits Bullseye: VISA INC. Stock Price Target Forecast Achieved with 14.24% Profit  ~1 min.

On December 9, 2022, QuantWave, the automated forecasting platform, issued a price target forecast for VISA INC. The signal indicated a long position with a price of 204.8 $....

STLAApril 7, 2025STELLANTIS N.V. Hits Price Target Forecast with 30.64% Profit Margin  ~1 min.

On December 17, 2024, QuantWave, the automated forecasting platform, issued a short signal for the stock STELLANTIS N.V. at a price of 12.27 $....